Literature DB >> 18757668

Hormonal contraception.

Paul D Blumenthal1, Alison Edelman.   

Abstract

Hormonal contraceptives have been a part of clinical practice for more than 40 years, and family planning programs, based largely on contraceptive provision, are regarded as one of the most successful public health interventions of the 20th century. Thus, discussion of family planning issues and contraceptive considerations has become an integral component of women's health care and one of the benchmarks of the traditional annual well-women visit. In terms of cost-effectiveness, prevention of unplanned pregnancies through contraceptive use has repeatedly been shown to be a highly cost-effective use of health care dollars. Options for effective hormonal contraception have expanded tremendously and include a variety of delivery options, including the pills both in traditional 21/7 format, and more recently in a 24/4 format, as well as a vaginal ring, a skin patch, implants, and the hormonally medicated intrauterine device. Importantly, the overall risks associated with hormonal contraceptives have been reduced as compared with older formulations, even for women with medical conditions. Many modern hormonal contraceptives also offer valuable noncontraceptive benefits. To help clinical decision making, a number of evidence-based guides have been published, and the American College of Obstetricians and Gynecologists has recently updated their practice bulletin on contraception use in women with medical conditions. In general, clinical protocols for provision of hormonal contraceptives have been streamlined, and unnecessary practices, tests, and procedures are identified and discouraged. In this review, we will summarize both technical and programmatic aspects of hormonal contraceptive use, and methods are discussed in order of efficacy from highest to lowest.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18757668     DOI: 10.1097/AOG.0b013e31818425b7

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  9 in total

1.  Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gels.

Authors:  M Y Roth; N Ilani; C Wang; S T Page; W J Bremner; R S Swerdloff; C Dart; R Sitruk-Ware; N Kumar; D Blithe; J K Amory
Journal:  Andrology       Date:  2013-09-30       Impact factor: 3.842

2.  Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, self-administered, online survey.

Authors:  David J Hooper
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  Hormonal contraception and pelvic girdle pain during pregnancy: a population study of 91,721 pregnancies in the Norwegian Mother and Child Cohort.

Authors:  E K Bjelland; P Kristiansson; H Nordeng; S Vangen; M Eberhard-Gran
Journal:  Hum Reprod       Date:  2013-07-25       Impact factor: 6.918

Review 4.  Putting risk into perspective: the US medical eligibility criteria for contraceptive use.

Authors:  Kathryn M Curtis; Naomi K Tepper; Polly A Marchbanks
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

5.  Effects of oral, vaginal, and transdermal hormonal contraception on serum levels of coenzyme q(10), vitamin e, and total antioxidant activity.

Authors:  Prabhudas R Palan; Felix Strube; Juraj Letko; Azra Sadikovic; Magdy S Mikhail
Journal:  Obstet Gynecol Int       Date:  2010-08-09

Review 6.  Beyond the Condom: Frontiers in Male Contraception.

Authors:  Mara Y Roth; John K Amory
Journal:  Semin Reprod Med       Date:  2016-03-04       Impact factor: 1.303

Review 7.  Male hormonal contraception.

Authors:  Mara Y Roth
Journal:  Virtual Mentor       Date:  2012-02-01

Review 8.  Male hormonal contraception: looking back and moving forward.

Authors:  M Y Roth; S T Page; W J Bremner
Journal:  Andrology       Date:  2015-10-09       Impact factor: 3.842

9.  Knowledge and attitudes of Latin American gynecologists regarding unplanned pregnancy and use of combined oral contraceptives.

Authors:  Luis Bahamondes; Josefina Lira-Plascencia; Ricardo Martin; Victor Marin; Maria Y Makuch
Journal:  Int J Womens Health       Date:  2015-05-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.